Oncolytics Biotech Inc. (NASDAQ:ONCY) stock is pricing at $0.71 after moving 0.34% thus far this session. Technical levels will be in focus as the volatility has increased given recent attention.
Investors might be searching far and wide for the next set of winning stocks to add to the portfolio. Many value investors may be on the lookout for stocks that are underpriced at current levels. Some investors may be looking for names that have the potential to see major growth in the next few years. Picking growth companies can be a bit riskier, but they may have much bigger potential for substantial returns. Other investors may be interested in finding companies that provide stable returns and pay out a solid dividend. Investors may even choose to piece together the portfolio with stocks from different categories. Having a diverse selection of stocks is typically recommended for longer-term portfolio health.
Based on recent analysis, Oncolytics Biotech Inc. (NASDAQ:ONCY) shares have been seen trading -60.12% off of the 50-day peak and 33.92% away from the 50-day bottom. In terms of the stock price in relation to its moving averages, company shares are 11.74% away from the 20-day moving average and -36.48% off of the 50-day average. If we take a longer approach, shares have been trading -59.33% away from the 200-day moving average.
As investors gear up for the stretch run towards the end of the year, the focus will be on which way stock market momentum seems to be shifting. Investors may be taking note of various economic reports and keeping a close eye on global political news. There are many factors that can affect the price of a stock. Tracking the markets from different angles may help to put together the bigger investing picture. Investors may be wondering if they have missed the boat as stocks have cooled off a bit recently. It may be wise to remember that there are always plenty of market opportunities to take advantage of. Diving into the fray may not be necessary until all the boxes are ticked off on the investor’s checklist.
Over the last year, Oncolytics Biotech Inc. (NASDAQ:ONCY)’s stock has performed
-83.28%. For the last six months, the stock has performed -62.44%. From the start of the calendar year, shares have been -60.78%. Zooming in closer, company stock has been -58.25% for the quarter, -26.82% over the past month, and 10.98% over the past week.
Often times, investors may become worried when the stock market is highly volatile. Being prepared for volatile situations can help ease the fears that come along with turbulence. Following a well-crafted plan might help ride out the ups and downs that are a normal part of dealing with the market. Investors should be prepared for market situations that provide ample opportunities. Although market downturns can be unsettling and cause panic, investors who are able to stay the course and keep calm may be able to spot good buying opportunities when the wider market is selling.
Disclaimer: The views, opinions, and information expressed in this article are those of the authors and do not necessarily reflect the official policy or position of any company stakeholders, financial professionals, or analysts. Examples of analysis performed within this article are only examples. They should not be utilized to make stock portfolio or financial decisions as they are based only on limited and open source information. Assumptions made within the analysis are not reflective of the position of any analysts or financial professionals.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.